吸入剂6大集采品种大跌!3个10亿大品种领跑,恒瑞、普锐特上榜,东阳光药、正大天晴改良型新药亮眼

米内网
Sep 25, 2025

精彩内容近日,吸入剂市场波澜再起,第十一批集采再有2个品种入围,立生医药(苏州)的吸入用布地奈德混悬液、浙江福瑞喜药业的盐酸丙卡特罗吸入溶液等3个产品同日获批上市,广东东阳光药业的HECB2100401吸入喷雾剂、山东京卫制药的JW202313吸入粉雾剂2个改良型新药同日获批临床。米内网数据显示,吸入剂在2025年上半年中国公立医疗机构终端销售额同比有所下滑,6个集采品种跌幅均超过10%。从...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10